• All News
• 2020
• 2019
• 2017
• 2016
• 2015
• 2014

Xenetic Biosciences Announces Positive Phase 1 Clinical Data for PulmoXen(TM) for Treatment of Cystic Fibrosis

Apr 7, 2014

Xenetic Biosciences Appoints Darlene Deptula-Hicks to Board of Directors

Apr 4, 2014

Xenetic Biosciences Announces Opening of Corporate Headquarters and R&D Facility in Lexington, MA

Mar 4, 2014

Xenetic Biosciences Announces Ticker Symbol Change to XBIO

Feb 14, 2014

• « Previous
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10